Pfizer CEO Read Will Pass The Torch To Bourla In 2019

Chief Operating Officer Albert Bourla will succeed Ian Read as CEO of Pfizer, taking over the top spot at a steady point in the big pharma's evolution. Bourla's near-term challenges will be navigating the loss of Lyrica and the changing US health care dynamics.

Albert Bourla

Pfizer Inc.'s next CEO will be its current Chief Operating Officer Albert Bourla, who will take over the top leadership spot at the big pharma Jan. 1, 2019, succeeding CEO Ian Read. The transition should be a smooth one and comes at a relatively steady point for Pfizer, if not necessarily for the drug industry. Read will remain executive chairman of Pfizer's board of directors.

Talk of a CEO succession plan had begun emerging among investors earlier this year, so the change is not a...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Leadership

More from Scrip